| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/15/2010 | EP1305432B1 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same |
| 09/15/2010 | EP1250055B1 Immune modulation with death receptor-induced apoptosis |
| 09/15/2010 | CN101835897A Detection of bacterium belonging to genus campylobacter which targets cytolethal distending toxin |
| 09/15/2010 | CN101835896A Production and use of epitope-tagged hepatitis c virus particle |
| 09/15/2010 | CN101835891A Treatment of diseases and disorders using self-renewing colony forming cells cultured and expanded in vitro |
| 09/15/2010 | CN101835890A Method of efficiently establishing induced pluripotent stem cells |
| 09/15/2010 | CN101835889A TR1 cells, mesenchymal stem cells and uses thereof |
| 09/15/2010 | CN101835888A Method for creating perfusable microvessel systems |
| 09/15/2010 | CN101835801A Transferrin variants and conjugates |
| 09/15/2010 | CN101835792A FOXM1 peptide and medicinal agent comprising the same |
| 09/15/2010 | CN101835479A Differentiation of multi-lineage progenitor cells to chondrocytes |
| 09/15/2010 | CN101831458A Method for breeding strong salt-tolerant drought-resistant plant and bivalent expression vector thereof |
| 09/15/2010 | CN101831443A Gene for encoding 5-enolpyrul-shikimate-3-phosphate synthase and application thereof |
| 09/15/2010 | CN101831437A Stress tolerance |
| 09/15/2010 | CN101831431A 启动子afb4及其应用 Promoter afb4 Its Applications |
| 09/15/2010 | CN101831425A Plant promoter related to photoperiod and application thereof |
| 09/15/2010 | CN101831411A Recombinant poxvirus expressing homologous genes inserted into the poxviral genome |
| 09/15/2010 | CN101831407A Hybridoma cell line of monoclonal antibody against African swine fever virus and secreted monoclonal antibody thereof |
| 09/15/2010 | CN101831406A New use of cell line LNCaP and cell line C4-2 |
| 09/15/2010 | CN101831405A Lung-targeting metastatic human hepatoma cell strain and establishing method thereof |
| 09/15/2010 | CN101831404A Lymph gland targeted metastatic human hepatoma cell strain and establishing method thereof |
| 09/15/2010 | CN101831403A Method for amplifying mesenchymal stem cells of human umbilical cord and placenta in vitro |
| 09/15/2010 | CN101831402A Experimental method for enzymolysis, digestion and acquisition in vitro of rabbit knee cartilage unit |
| 09/15/2010 | CN101831401A Method for inducing mesenchymal stem cell to differentiate into neural stem cells in vitro |
| 09/15/2010 | CN101831399A Method for preparing sweet potato solid culture medium |
| 09/15/2010 | CN101831398A Rhodiola fastigiata bud induction culture medium with dimethyl sulfoxide, preparation method thereof and use thereof |
| 09/15/2010 | CN101831385A Jar external circulatory packed bed type cell reactor and method for cultivating animal cell |
| 09/15/2010 | CN101831383A Method and device for separating sperms |
| 09/15/2010 | CN101830986A Fusion protein polymer |
| 09/15/2010 | CN101830973A Rice protein OsAHL and use thereof |
| 09/15/2010 | CN101830972A Fluorescence complementary system based on green fluorescent protein sfGFP |
| 09/15/2010 | CN101829359A Acellular ligament stent and seed cell compound culture method |
| 09/15/2010 | CN101294158B Small numerator interference RNA for inhibiting vascellum endometrial hyperplasia |
| 09/15/2010 | CN101186900B Process for producing retinal neurocyte and retinal neurocyte produced by the process |
| 09/15/2010 | CN101058791B Method of culturing culture by roll load and bioreactor |
| 09/15/2010 | CN101012449B Lymphocyte separation liquid and method of separating spleen lymphocyte |
| 09/14/2010 | US7795510 Inbred corn line PHCK5 |
| 09/14/2010 | US7795509 Tobacco products with reduced nicotine |
| 09/14/2010 | US7795504 Coordinated decrease and increase of gene expression of more than one gene using transgenic constructs |
| 09/14/2010 | US7795498 Use of AtBG1 gene for the generation of transgenic plants with increased resistance to various abiotic stress |
| 09/14/2010 | US7795494 Transgenic animals capable of generating antibodies, e.g., human monoclonal antibodies, specific for the product of a gene of interest |
| 09/14/2010 | US7795493 tissues, organs and cells for use in xenotransplantation |
| 09/14/2010 | US7795412 encodes polypeptide that is an epitope tag or a Fc region of an immunoglobulin; used in modulating cell proliferation, inducing neovascularization and diagnosis of tumors |
| 09/14/2010 | US7795403 Antibodies directed against prothrombin fragment F1+2, the preparation and use thereof |
| 09/14/2010 | US7795398 for preventing oomycete infection of potato and/or tomato; disease resistant plants; Phytophthora infestans |
| 09/14/2010 | US7795397 Red and near infrared flourescent phyotochrome |
| 09/14/2010 | US7795395 encoding Xenorhabdus toxin complex (TC) proteins; transgenic plants and host cells expressing Xenorhabdus toxin complex (TC) proteins and having resistance to insects; pest control |
| 09/14/2010 | US7795394 Saitohin gene and uses of same |
| 09/14/2010 | US7795391 Protein showing enhanced expression in cancer cells |
| 09/14/2010 | US7795387 detecting the decreased transcription of messenger RNA transcribed from an RDCVF1 or RDCVF2 polypeptide, in the eye of a human, wherein said decreased transcription is diagnostic of such human's suffering from retinal dystrohy |
| 09/14/2010 | US7795293 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine) |
| 09/14/2010 | US7795214 polypeptide with at least one amino acid replacement at position at 132, 134, 170, or 181; agonist of MET receptor; induce DNA synthesis, protect from liver damage from acetaminophen; gene therapy; promote cell growth angiogenesis, treatment of cardiovascular, hepatic, musculoskeletal, neuronal diseases |
| 09/14/2010 | US7795208 Using enzyme inhibitors of histone deacetylase to enhance progenitor cell differentiation; regenerative medicine and treatment of nervous system disorders |
| 09/14/2010 | US7795202 Inducing the migration of progenitor cells into regions of nervous tissue damage; identify region of nervous tissue damage, incubate with progenitor cells and transforming growth factor, monitor therapeutic response; repair of nervous system injuries or neurodegenerative disorders; tissue repair |
| 09/14/2010 | US7795032 Methods for proliferating cardiomyocytes and recombinant vectors therefor |
| 09/14/2010 | US7795029 Using nutrient broth and porous solid support to culture and sow heterotrophic somatic plant embryo or germinant of conifer; tissue engineering and plant propagation |
| 09/14/2010 | US7795028 Modulating developmental transitions in plants |
| 09/14/2010 | US7795027 Extracellular matrix composite materials, and manufacture and use thereof |
| 09/14/2010 | US7795026 Methods for obtaining human embryoid body-derived cells |
| 09/14/2010 | US7795025 Methods for producing enriched populations of human retinal pigment epithelium cells |
| 09/14/2010 | US7795024 for expansion of hematopoietic stem cells; stem cells are cultured and differentiated cells and endogenous growth factors are removed (depleted) permitting long term culture and expansion of the stem cells; for transplantation (hematopoietic rescue) |
| 09/14/2010 | US7795023 Identification of a pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell |
| 09/14/2010 | US7795022 tissue graft construct for repairing diseased or damaged tissues; comprising a matrix composition that has been seeded with liver cells, endothelial cells and at least one additional preselected exogenous population of cells |
| 09/14/2010 | US7795021 CNS glial restricted precursor cells which generate oligodendrocytes and at least two distinct populations of astrocytes, but not neurons; isolated from a mixture of cells by positive immunoselection with an A2B5 antibody |
| 09/14/2010 | US7795020 Prepared from autologous lymphoma cells transfected with emm55; for canines; the modified cancer cells are highly immunogenic to the host, yet show no toxic side effects |
| 09/14/2010 | US7795018 expresses CD14, CD34, CD45, type I collagen, and HLA-DR; differentiates into osteoblasts, skeletal myoblasts or chondrocytes; obtained by culturing peripheral blood mononuclear cells (PBMCs) in vitro on fibronectin; noninvasive; will not cause rejection at the time of cell transplantation |
| 09/14/2010 | US7795001 Comprises polynucleotides coding proteins associated with generating macrolide antibiotics; bactericides; polyketide synthase |
| 09/14/2010 | US7794993 Carbonyl reductase, gene thereof and method of using the same |
| 09/14/2010 | US7794977 Using transgenic cell comprising stabilizing-antirepression sequences (STAR) a bioreactor for production of preferential polypeptides |
| 09/14/2010 | US7794976 Using expression vector comprising 3' untranslated region of immunoglobulin light chain and an epstein-barr viral origin of replication as gene transfer vehicle for expression of heterologus gene sequences in cells |
| 09/14/2010 | US7794975 Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide |
| 09/14/2010 | US7794957 Eukaryotic genes involved in adult lifespan regulation |
| 09/14/2010 | US7794956 Gab1 involvement in glucose homeostasis regulation by hepatocytes |
| 09/14/2010 | US7794955 Transfecting a eukaryotic cell with nucleotide sequence, contacting cell with a candidate compound; determining distribution of expressed protein in cell by detecting the distribution of detectable moiety in cell; drug screening for their ability to interact with transmembrane proteins |
| 09/14/2010 | US7794942 Expression vector comprising viral polyprotein for use as tool in developng vaccine against hepatitis-C infection; improving transfection efficiencies |
| 09/14/2010 | US7794941 Providing a DNA sample, detecting the amplification of a nucleic acid sequence in chromosomal region 8p22, amplification indicates that the patient has, or is susceptible of developing cancer; inhibition of FGF-20 activity inhibits the growth of cancer cells |
| 09/14/2010 | US7794928 Norovirus detection, methods and compositions therefor |
| 09/14/2010 | US7794756 Methods of using antibodies to VEGF-C |
| 09/14/2010 | US7794723 treatment or prophylaxis of cancer using proteins or peptides that elicit T cell mediated immunity; vaccination |
| 09/14/2010 | US7794719 variable regions peptides for immunizing against amyloid plaque formation; biodrug for dementia, Alzheimer's disease, neuropathy, Down's syndrome, Creutzfeld Jacob disease, Parkinson's disease, amyotropic lateral sclerosis; neuroprotectants; hemostatic agent |
| 09/14/2010 | US7794715 T-cell immune response cDNA 7 (TIRC7) antagonist; rheumatoid arthritis; comprising all three complementarity determining regions (CDRs) of the VH and all three complementarity determining regions (CDRs) of the VL variable regions |
| 09/14/2010 | US7794710 Identifying a mammal with, or at risk of developing, cancer; cells of the cancer are identified as expressing B7-H1 molecules on their surfaces, and administering an agent that interferes with interaction between B7-H1 and t-cells |
| 09/14/2010 | US7794707 ACE2 activation for treatment of heart, lung and kidney disease and hypertension |
| 09/14/2010 | US7794705 comprising a chemotactic hematopoietic stem cell product and methods of use thereof in repairing injury caused by vascular insufficiency, including infarcted myocardium; contains a subpopulation of potent CD34+/chemokine receptor type 4 (CXCR-4+) cells |
| 09/14/2010 | US7794704 culturing a multilayer of human embryonic stem cells, for a sufficient time to allow for the appearance of putative cells comprising brown pigment dispersed within their cytoplasm, culturing the putative cells to form a cell monolayer containing cells that are Pax6 negative and bestrophin positive |
| 09/14/2010 | US7794702 Expression vector for use as gene transfer tool in treatment of cardiovascular disorders |
| 09/14/2010 | CA2452800C Flow control metering system and method for controlling filtration of liquid-based specimens |
| 09/14/2010 | CA2322792C Polypeptides homologous to vegf and bmp1 |
| 09/14/2010 | CA2306346C Tissue-engineered tubular construct having circumferentially oriented smooth muscle cells |
| 09/14/2010 | CA2262014C Adipogenic differentiation of human mesenchymal stem cells |
| 09/14/2010 | CA2195970C Production of collagen in the milk of transgenic mammals |
| 09/14/2010 | CA2146693C Antibodies against epitopes with homology to self antigens, methods of preparation and applications thereof |
| 09/14/2010 | CA2087883C Beta-alethine use in cell culture and therapy |
| 09/10/2010 | WO2010102052A2 Methods of inhibiting photoreceptor apoptosis |
| 09/10/2010 | WO2010101921A2 Tumor-selective e1a and e1b mutants |
| 09/10/2010 | WO2010101870A1 Compositions and methods for generating interleukin-35-induced regulatory t cells |
| 09/10/2010 | WO2010101844A1 Method and material for site activated complexing of biologic molecules |
| 09/10/2010 | WO2010101256A1 Thermotolerant transglutaminase originating in actinomyces |
| 09/10/2010 | WO2010101249A1 Method for enhancing function of t cell |
| 09/10/2010 | WO2010101248A1 Cell proliferation inhibitor and method for screening same |